A1chieve® Study: Global problems of Compensation of Diabetes Mellitus Type 2

Main Article Content

V.I. Pankiv
Марина Владимировна Власенко
N. A. Kravchun
Евгений Николаевич Марциник

Abstract

No abstract

Article Details

How to Cite
Pankiv, V., М. В. Власенко, N. A. Kravchun, and Е. Н. Марциник. “A1chieve® Study: Global Problems of Compensation of Diabetes Mellitus Type 2”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), no. 2.42, Mar. 2012, pp. 19-28, doi:10.22141/2224-0721.0.2.42.2012.176852.
Section
Original Researches

References

Приказ МЗ Украины № 574 от 05.08.2009.

Heller S., Colagiuri S., Vaaler S., Wolffenbuttel B.H.R. et al. Hypoglycaemia with insulin aspart: a double-blind, randomised, crossover trial in subjects with Type 1 diabetes // Diabetic Medicine. — 2004. — Vol. 21. — P. 769-775.

De Leeuw I., Selam J.-L., Skeie S. et al. Insulin detemir-based used in basal-bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin // Diabetes Obes. Metab. — 2005. — Vol. 7, № 1. — P. 73-82.

Garber A.J., Clauson P., Pedersen C.B., Kølendorf K. Lower risk of hypoglycemia with insulin detemir than with NPH insulin in older persons with type 2 diabetes: a pooled analysis of phase 3 trials // J. Am. Geriatric. Soc. — 2007. — 55(11). — 1735-40.

Meneghini L.F., Rosenberg K.H., Koenen C., Merilainen M.J., Luddeke H.J. Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain in patients with type 2 diabetes who were insulin naive or treated with NPH or insulin glargine: clinical practice experience from a German subgroup of the PREDICTIVETM // Diabetes Obes. Metab. — 2007. — 9(3). — 418-27.

Luddeke et al. PREDICTIVE™ — a global, prospective observational study to evaluate insulin detemir treatment in types 1 and 2 diabetes: baseline characteristics and predictors of hypoglycaemia from the European cohort // Diabetes, Obesity and Metabolism. — 2007. — 9. — 428-434.

Dornhorst A., Hernandez F.O., Koenen C., Lüddeke H.-J. Levemir (insulin Detemir) Reduces Weight and Improves Blood Glucose Levels Poster presentation at: 19th world congress of the International Diabetes Federation. — Capetown, South Africa, December 3–7, 2006.

Selam J.L., Koenen C., Weng W., Meneghini L. Improving glycemic control with insulin detemir using the 303 algorithm in insulin naive patients with type 2 diabetes: a subgroup analysis of the US PREDICTIVE 303 study // Curr. Med. Res. Opin. — 2008. — 24(1). — 11-20.

Porte D.Jr., Baskin D.G., Schwartz V.W. Insulin signaling in the central nervous system a critical role in metabolic homeostasis and disease from C. elegans to human // Diabetes. — 2005. — 54(5). — 1264-76.

Hennige A.M., Sartorius T. et al. Tissue selectivity of insulin detemir action in vivo // Diabetologia. — 2006. — 49. — 1274-1282.

Schwartz M.W. Brain parthways controlling food intake and body weight // Science. — 2000. — 289. — 2066-7.

Horden S.V.M., Wrigt J.E. et al. Comparison of effects on glucose and lipid metabolism of equipotent doses of insulin detemir and NPH insulin with a 16-hr euglycaemic clamp // Diabetologia. — 2005. — 48. — 420-426.

Hermanse K., Tamer S. The advantage of less weight gain with baseline obesity when insulin Detemir rather than NPH insulin added to oral agents in Type 2 Diabetes // Diabetes. — 2005. — 54 (Suppl.1). — A 64.

Haak T. et al. Lower within subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes // Diabetes Obesity Metabolism. — 2005. — 7(1). — 56-64.

Постанова Кабінету міністрів України від 19 серпня 2009 р. № 877 «Про затвердження Державної цільової програми «Цукровий діабет»» на 2009–2013 роки.

Global guideline for Type 2 diabetes. — Brussels: International Diabetes Federation, 2005.

Nathan D.M. et al. Medical management of hyperglycaemia in type 2 Diabetes Mellitus: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes // Diabetologia. — 2009. — 52. — 17-30.

Va/DoD Clinical practice Guideline for the management of diabetes mellitus, August 2010, Version 4.0.

Road Maps To Achieve Glycemic Control in Type 2 Diabetes Mellitus // Endocrine Practice. — 2007. — Vol. 13, № 3 May/June.

Asakura T., Seino H. Dosing accuracy of two insulin pre-filled pens // Current Med. Research and Opinion. — 2008. — 24. — 1429-1434.

Valensi et al. Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix® 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE™ observational study // Int. J. Clin. Pract. — 2009. — 63, 3. — 522-531.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 11 12 > >>